DAFTAR PUSTAKA

C. A. Naranjo, M. D., U. Busto, P. D., E. M. Sellers, M.D., P. D., P. Sandor, M. D.,

I. Ruiz, P. D., E. A. Roberts, M. D., … D. J. Greenblatt, M. D. (1981). A
Method for Estimating the Probability of Adverse Drug Reactions. Clin.
Pharmacol. Ther, 239–245.

Dana, W. J., Fuller, M. A., Goldman, M. P., Golembiewski, J. A., Gonzales, J. P.,
Lowe, J. F., & Snoke, J. (2012). Drug Information Handbook (21st ed.). Ohio:
Lexicomp.

Drugs.com. Ketorolac. https://www.drugs.com/mtm/ketorolac-oral-injection.html.

Diakses 25 Februari 2022.

Joint Formulary Committee. 2021. British National Formulary. Edisi 81. London:
British Medical Association and Royal Pharmaceutical Society.

Medscape. 2021. https://reference.medscape.com/drug/ketorolac-343292.

[Diakses pada 25 Februari 2022]

MIMS. Ketorolac.
https://www.mims.com/indonesia/drug/info/ketorolac?mtype=generic.
[Diakses pada 25 Februari 2022]

Mir, F. A. (2021). British National Formulary (81st ed.). London: British Medical
Association and Royal Pharmaceutical Society.

PubMed. (2021). Ketorolac - StatPearls - NCBI Bookshelf. Retrieved from

https://www.ncbi.nlm.nih.gov/books/NBK545172/

Reinhart, D. J. (2000). Minimising the Adverse Effects Of Ketorolac. Druf Safety,

22(6), 487–497.